ArticleOncology reports2021

Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies.

Sanmei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.